A new study indicates that face masks did not significantly lower Covid-19 infection risk after the initial Omicron wave, highlighting the need for adaptable strategies and further research as risk factors evolve.
New findings from the University of East Anglia suggest that wearing face masks did not reduce the risk of Covid infection after the initial rise of the Omicron variant. An analysis of official data indicated that the risk factors for infection changed notably when the dominant Covid variant in the UK shifted from Delta to Omicron in December 2021.
These included wearing a mask, a history of foreign travel, household size, whether people were working or retired, and contact with children or over-70s.
Lead author Professor Paul Hunter, of Norwich Medical School at the University of East Anglia (UEA), said: "Early in the pandemic there were many studies published looking at risk factors for catching Covid, but far fewer studies after the first year or so. Our research shows that there were changes in some risk factors around the time that the Omicron BA.2 variant became dominant."
Co-author Dr. Julii Brainard, of UEA's Norwich Medical School, said: "This isn't totally surprising because laboratory evidence suggests that the Omicron variant was better able to infect the cells lining the upper respiratory tract than previous variants and so be more transmissible. Management of infection risk needs to be agile, adapting to epidemic development and better-quality information when it emerges. To prevent infections we need to have a good view of which factors might be most or least relevant. If those factors can change, we need to be alert to that happening."
Methodology and Key Findings from the Data
The researchers analyzed data available from the Office for National Statistics (ONS) Covid survey in England, which compared infection rates with an ongoing household survey of the population to estimate how many people had infections. From November 2021 to May 2022, the ONS also asked people questions about their circumstances and habits to see if those factors could be linked to the risk of positivity.
Professor Hunter added: "We used this dataset to look for constancy or change in the importance and direction of potential risk factors for testing positive. We applied a statistical method called meta-regression to do this."
The study found that changes to risk factors included:
- In November 2021, always wearing face masks at work, school, or in enclosed spaces was associated with a reduced risk of being infected in both adults and children, but after the first Omicron wave, it was not.
- Living in a house with five or more people was a risk at the beginning but by the end of the study period, people in larger households (four and above) had negligibly greater risk than people living in singleton households.
- Early overseas travel was not associated with increased risk, but later on, it was.
- Working in health or social care or in contact with others, was often found to be important in the first year of the pandemic, but was not associated with an overall higher or changing risk of infection in the study period.
- Being of ethnic minority was strongly associated with increased risk in the first few months of the UK epidemic, but was associated with lower risk and no significant trend change during the study's full monitoring period.
- Being retired was associated with reduced risk compared to those in work overall, but any protective effect had disappeared by February 27, 2022, which coincided with the start of the second Omicron wave.
- By the end of February 2022, it became apparent that there was a decrease in risk for adults living with children aged 16 or under.
- People under 70 who lived with someone aged 70 or older initially had a lower likelihood of testing positive, but this protective effect diminished by about mid-February, 2022.
The researchers said the balance of evidence is that wearing face coverings reduces transmission of respiratory infections in community settings and reduces transmission of Covid-19. The question, however, is by how much.
Conclusion and Implications for Future Research
A systematic review of pre-pandemic evidence and analysis of original survey data during the COVID-19 pandemic both indicated that mask-wearing could or did reduce transmission of SARS-CoV-2 by about 19pc. But these conclusions were derived mainly from data prior to the emergence of Omicron variants.
This latest research found that prior to Omicron BA.2, never wearing a mask was associated with an increased risk of around 30pc in adults and 10pc in children. But by the second Omicron wave (mid to late February 2022 onwards) there was no protective effect from mask-wearing in adults and possibly an increased risk of infection in children.
Professor Paul Hunter commented: "It should not be a surprise that risk factors change during a pandemic due to a highly infectious disease with a short duration of immunity like Covid. So-called SEIRS (Susceptible, Exposed, Infected, Recovered, Susceptible) models of epidemics predict that as such an infection becomes endemic risk factors that powered the epidemic in its early stages become less important and the rate at which people lose immunity becomes more important in driving infection rates."
Dr Brainard added: "A lot of potential risk factors for catching Covid didn't change during this period, and that's important to know too. We offer some possible explanations for why the changes may have happened, but we would need more focused research to understand for sure why there were changes in some risk factors."
Reference: "Changing risk factors for developing SARS-CoV-2 infection from Delta to Omicron" by Paul R. Hunter and Julii Brainard, 15 May 2024, PLOS ONE.
DOI: 10.1371/journal.pone.0299714
The study was funded by the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emergency Preparedness and Response at King's College London in partnership with the UK Health Security Agency (UKHSA) and in collaboration with the University of East Anglia.
News
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]















